According to the World Economic Forum, by next year around 70 percent of the US's disposable income will be held by people over 60. As a driving force of innovation, longevity presents a massive growth opportunity for those companies willing to adapt. Yet questions remain about how to transform the traditionally altruistic aging field into commercially successful business models.
The Economist will bring together corporate innovators, healthcare executives, investors, technology and scientific experts and policymakers for the event.
Topics that will be explored:
- The Economics of longevity
- Capitalizing on the silver tsunami
- Regenerative medicine
- Disruptive technology
- Investing in longevity
- The policy and regulatory landscape
- Ageing innovators around the world
- Can we afford to live longer?
Who should attend?
- Life science and health-care executives
- Corporate innovation executives
- Heads of R&D
- Entrepreneurs and innovators
- Technology transfer officers, incubators and aged-care consultants
Standard Rate: USD 1395
Super Early Bird Rate: USD 995
Early Bird Rate: USD 1095
VIP Table: USD 9500
Speakers: Paul Irving Chairman, Milken Institute Centre for the Future of Aging, Rakesh Kochhar Associate director, Pew Research Center, Randy Swanson Chief executive, Care Innovations, Frank Leyhausen General manager, MedCom International, J. Craig Venter Co-founder, executive chairman and chief executive, Human Longevity Inc, Brian K. Kennedy President and chief executive, Buck Institute for Research on Aging, Matt Kaeberlein Professor of Pathology and Adjunct Professor of Genome Sciences, University of Washington, Sonya Kim Chief executive and founder, One Caring Team, David Lindeman Director, Center for Technology and Aging, Thomas Goetz Co-founder and chief executive, Iodine, Kash Kapadia Vice-president and general manager, Digital Health, Stanford Health Care, Lisa Suennen Managing partner, Venture Valkyrie, David Sabow Head of life science and healthcare banking, Silicon Valley Bank, Laura Deming Partner, The Longevity Fund, Esther Dyson Executive founder, Way to Wellville, R. Dale Hall Managing Director of Research, Society of Actuaries, Jacquelyn B. James Co-director, Boston College Center on Aging & Work, Nir Barzilai Professor of Medicine and Genetics and director of the Institute for Aging Research, Albert Einstein College of Medicine, Joon Yun Managing partner and president, Palo Alto Investors, James Firman President and chief executive, National Coalition on Aging
Category: Conferences, Business and Economics